Dr Reddy's Laboratories SG&A Expense (Annual) Analysis

Dr Reddy's Laboratories Ltd (RDY)

68.26 -1.04 (-1.50%) USD | NYSE | May 17, 16:00

68.26 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2001. Upgrade now.

Date	Value
March 31, 2024	1.434B
March 31, 2023	848.46M
March 31, 2022	833.38M
March 31, 2021	734.81M
March 31, 2020	705.90M
March 31, 2019	695.89M
March 31, 2018	726.80M
March 31, 2017	691.53M
March 31, 2016	698.63M
March 31, 2015	696.66M
March 31, 2014	643.64M
March 31, 2013	630.57M

Date	Value
March 31, 2012	626.76M
March 31, 2011	520.35M
March 31, 2010	475.14M
March 31, 2009	458.01M
March 31, 2008	420.09M
March 31, 2007	312.59M
March 31, 2006	182.43M
March 31, 2005	151.43M
March 31, 2004	143.21M
March 31, 2003	103.37M
March 31, 2002	76.70M
March 31, 2001	61.43M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

705.90M

Minimum

2020

1.434B

Maximum

2024

911.26M

Average

833.38M

Median

2022

SG&A Expense (Annual) Benchmarks